NFKB1 and neoplasm: S16, B and D) and strong inflammation-related TF activation, including Irf1 and Nfkb1 (Fig. 6E), akin to previously reported tumor-infiltrating CCR7+ DCs that secrete IL-12 and activate T cells to increase antitumor activity (45).